🔎 Trials Near Me

Hem › Gliom › Texas › Houston

Kliniska studier för Gliom i Houston, TX

23 studier för Gliom söker deltagare vid platser i och runt Houston (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

RekryterarFas 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
12 Months – 21 Years · Alla kön · Uppdaterad 1 okt. 2026 · NCT05099003

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

RekryterarFas 1/2
  • Baylor College of Medicine, Houston
Upp till ålder 25 · Alla kön · Uppdaterad 25 sep. 2026 · NCT04094610

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

RekryterarFas 1
  • M D Anderson Cancer Center, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT03896568

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

RekryterarFas 2
  • Texas Children's Hospital, Houston
12 Months – 39 Years · Alla kön · Uppdaterad 21 sep. 2026 · NCT06838676

MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas

Rekryterar
  • M D Anderson Cancer Center, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT04373720

Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

RekryterarObservationsstudie
  • M D Anderson Cancer Center, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT04771806

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

RekryterarFas 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
36 Months · Alla kön · Uppdaterad 9 sep. 2026 · NCT07076498

Targeted Pediatric High-Grade Glioma Therapy

RekryterarObservationsstudie
  • Texas Children's Hospital, Houston
12 Months – 39 Years · Alla kön · Uppdaterad 8 sep. 2026 · NCT05839379

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

RekryterarFas 1
  • MD Anderson Cancer Center, Houston
36 Months – 22 Years · Alla kön · Uppdaterad 4 sep. 2026 · NCT03911388

Study of Olutasidenib and Temozolomide in HGG

RekryterarFas 2
  • Texas Children's Hospital, Houston
Ålder 12 till 39 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

RekryterarFas 3
  • MD Anderson Cancer Center, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

RekryterarFas 2
  • Texas Children's Hospital, Houston
Ålder 3 till 39 · Alla kön · Uppdaterad 24 aug. 2026 · NCT05096481

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

RekryterarObservationsstudie
  • M D Anderson Cancer Center, Houston
Alla åldrar · Alla kön · Uppdaterad 21 aug. 2026 · NCT01772771

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

RekryterarFas 1/2
  • Research Site, Houston
Ålder 18 till 130 · Alla kön · Uppdaterad 12 aug. 2026 · NCT05417594

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

RekryterarFas 1
  • Excel Diagnostics & Nuclear Oncology Center, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 7 aug. 2026 · NCT07733674

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

RekryterarFas 1
  • Texas Children's Hospital, Houston
12 Months – 25 Years · Alla kön · Uppdaterad 3 aug. 2026 · NCT04099797

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

RekryterarFas 2
  • University of Texas MD Anderson Cancer Center, Houston
Ålder 8 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT05503797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

RekryterarTidig fas 1Friska volontärer välkomna
  • Texas Children's Hospital, Houston
Ålder 1 till 21 · Alla kön · Uppdaterad 29 juni 2026 · NCT06333899

Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas

RekryterarTidig fas 1
  • M D Anderson Cancer Center, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 12 juni 2026 · NCT05804227

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

RekryterarFas 2
  • Texas Children's Hospital, Houston
12 Months – 39 Years · Alla kön · Uppdaterad 29 maj 2026 · NCT05843253

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

RekryterarFas 1
  • MD Anderson Cancer Center, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 20 apr. 2026 · NCT06326411

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

RekryterarFas 1/2
  • MD Anderson Cancer Center, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 13 apr. 2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

RekryterarTidig fas 1
  • Texas Children's Hospital, Houston
Upp till ålder 21 · Alla kön · Uppdaterad 18 mars 2026 · NCT04655404

Gliom-studier i andra städer

Andra studier i Houston

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.